REED-LANE INC 359 NEW WARK, — Cetirizine Importer Profile
Pharmaceutical Importer · #6 buyer for Cetirizine · $1.3M import value · 28 shipments · UNITED STATES · DGFT Verified
REED-LANE INC 359 NEW WARK, is the #6 importer of Cetirizine from India with $1.3M in import value and 28 verified shipments. REED-LANE INC 359 NEW WARK, holds a 0.8% market share in Cetirizine imports based in UNITED STATES. The company sources from 2 verified suppliers across 13 formulations shipped to 1 country.
REED-LANE INC 359 NEW WARK, — Cetirizine Import Profile: Suppliers, Formulations & Sources
Who Actually Supplies Cetirizine to REED-LANE INC 359 NEW WARK,?
Verified from 28 customs shipment records
| Supplier | Value | Shipments | % Share |
|---|---|---|---|
| DR.REDDY'S LABORATORIES LIMITED | $1.2M | 26 | 92.0% |
| DR REDDYS LABORATORIES LIMITED | $100.0K | 2 | 8.0% |
REED-LANE INC 359 NEW WARK, sources Cetirizine from 2 verified Indian suppliers based on 28 customs records. The primary supplier is DR.REDDY'S LABORATORIES LIMITED accounting for 92.0% of imports.
How Does REED-LANE INC 359 NEW WARK, Compare to Nearest Cetirizine Importers?
Buyers ranked immediately above and below #6 by import value
| # | Buyer | Country | Import Value | Shipments | Avg/Shipment |
|---|---|---|---|---|---|
| 8 | AJANTA PHARMA PHILIPPINES INC | PHILIPPINES | $1.0M | 20 | $50.0K |
| 12 | SHAMS NOORI PHARMA TRADING COMPANY | AFGHANISTAN | $1.0M | 20 | $50.0K |
| 6 | REED-LANE INC 359 NEW WARK, ★ | UNITED STATES | $950.0K | 19 | $50.0K |
| 5 | OOO DR. REDDYS LABORATORIES | RUSSIA | $850.0K | 17 | $50.0K |
| 3 | THE CATHAY DRUG CO. INC | PHILIPPINES | $550.0K | 11 | $50.0K |
REED-LANE INC 359 NEW WARK, ranks #6 among 1,814 Cetirizine importers from India. Average shipment value of $50.0K compared to the market average of $12.2K. The closest competitors by value are AJANTA PHARMA PHILIPPINES INC and SHAMS NOORI PHARMA TRADING COMPANY.
Where Does REED-LANE INC 359 NEW WARK, Import Cetirizine To?
Destination countries from 28 verified shipments
| Country | Value | Shipments | Share |
|---|---|---|---|
| UNITED STATES | $1.3M | 28 | 100.0% |
REED-LANE INC 359 NEW WARK, imports Cetirizine to 1 country. The primary destination is UNITED STATES receiving 100.0% of shipments worth $1.3M.
What Cetirizine Formulations Does REED-LANE INC 359 NEW WARK, Import?
| Formulation | Value | Shipments |
|---|---|---|
| LEVOCETIRIZINE DIHYDROCHLORIDE TABLETS U | $250.0K | 5 |
| CETIRIZINE HCI TABLETS USP 10MG (OVAL SHAPE) 7500S | $213.8K | 6 |
| LEVOCETIRIZINE DIHYDROCHLORIDE TABLETS USP 5MG 10000S (3063 X 10000S PACKS=30630000 NOS) | $150.0K | 3 |
| LEVOCETIRIZINE DIHYDROCHLORIDE TABLETS USP 5MG 10000S (1764 X 10000S=17640000 NOS) | $150.0K | 3 |
| CETIRIZINE HCL TABLETS USP 10MG (OVAL SHAPE) 7500S | $116.3K | 3 |
| LEVOCETIRIZINE DIHYDROCHLORIDE TABLETS USP 5 MG 10000 S 294 X 10000 S PACKS = 2940000 NOS | $50.0K | 1 |
| CETIRIZINE HCL TABLETS USP 10MG OVAL SHAPE 7500S | $50.0K | 1 |
| CETIRIZINE HCI TABLETS USP 10MG(OVAL SHAPE)7500 S(BATCH NO.C2402550)(3675000 SU) | $50.0K | 1 |
| CETIRIZINE HCI TABLETS USP 10MG(OVAL SHAPE)7500 S(BATCH NO.C2402551)(3682000 SU) | $50.0K | 1 |
| LEVOCETIRIZINE DIHYDROCHLORIDE TABLETS USP 5MG 10000S (1464X10000S=14640000 NOS) | $50.0K | 1 |
REED-LANE INC 359 NEW WARK, imports 13 distinct Cetirizine formulations from India. The top formulation is LEVOCETIRIZINE DIHYDROCHLORIDE TABLETS U with 5 shipments worth $250.0K.
Regulatory Requirements: Importing Cetirizine into United States
What REED-LANE INC 359 NEW WARK, and other importers must comply with to import Cetirizine from India
Regulatory Authority
U.S. Food and Drug Administration (FDA)
Approval Process for Generic Cetirizine
Abbreviated New Drug Application (ANDA) for generic drugs, requiring bioequivalence studies and compliance with 21 CFR. Indian manufacturing sites must pass FDA pre-approval inspection.
Typical timeline: 10–18 months for ANDA approval
GMP Requirements
FDA cGMP compliance (21 CFR 210/211); facility inspection by FDA prior to approval
Import Licence & Documentation
Drug Listing with FDA; Import Alert screening; Customs entry via FDA PREDICT system
Labeling & Packaging
US-specific labeling per 21 CFR 201 including NDC number, lot, expiry, dosage in English
Note: Subject to FDA Import Alerts and Automatic Detention if facility has open Form 483 observations.
Regulatory information is provided for general reference based on publicly available FDA guidelines for pharmaceutical imports. Requirements may vary by specific drug formulation, dosage form, and therapeutic classification. Importers should consult directly with FDA or qualified regulatory affairs professionals for case-specific guidance.
Who Are the Top Buyers of Cetirizine from India and How Much Does REED-LANE INC 359 NEW WARK, Import?
India exported $22.0M worth of Cetirizine through 8,785 shipments from 649 suppliers to 149 countries, serving 1,814 buyers globally. REED-LANE INC 359 NEW WARK, imports $1.3M of this total, accounting for 0.8% of India's Cetirizine exports with 28 shipments from UNITED STATES. This is verified from 28 customs shipment records covering 13 distinct formulations.
What Is the Average Order Value for REED-LANE INC 359 NEW WARK,'s Cetirizine Imports?
REED-LANE INC 359 NEW WARK,'s average Cetirizine order value is $44.8K per consignment, based on 28 shipments totaling $1.3M. REED-LANE INC 359 NEW WARK, is based in UNITED STATES and ranks #6 among all Cetirizine importers from India by value. The company sources from 2 verified suppliers in India.
Who Supplies Cetirizine to REED-LANE INC 359 NEW WARK,?
REED-LANE INC 359 NEW WARK, sources Cetirizine from 2 verified Indian suppliers: DR.REDDY'S LABORATORIES LIMITED ($1.2M, 92.0%), DR REDDYS LABORATORIES LIMITED ($100.0K, 8.0%). This is based on 28 customs records.
How Does REED-LANE INC 359 NEW WARK, Compare to Other Cetirizine Importers?
REED-LANE INC 359 NEW WARK, ranks #6 among 1,814 Cetirizine importers from India with a 0.8% market share. The top 3 importers are GRANULES CONSUMER HEALTH ($2.9M), RISING PHARMA HOLDINGS, INC. ($2.5M), RELONCHEM LTD CHESHIRE HOUSE, ($2.4M). REED-LANE INC 359 NEW WARK, processed 28 shipments from UNITED STATES.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Cetirizine — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- European Medicines Agency
- WHO Essential Medicines
- Invest India — Pharma Sector
- India Trade Statistics (DGFT)
Verify import regulations and drug registration requirements with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Cetirizine shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature and HS code classification.
- 2.Buyer Identification: REED-LANE INC 359 NEW WARK, matched across shipments using first-3-word normalization of the consignee field, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort buyer rankings.
- 4.Market Share: Calculated as REED-LANE INC 359 NEW WARK,'s capped import value divided by total capped export value for Cetirizine across all Indian exporters.
- 5.Verified Records: This page is backed by 28 individual customs records matching REED-LANE INC 359 NEW WARK, importing Cetirizine, covering 13 formulations from 2 verified suppliers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 149+ countries, 1,814+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Cetirizine Import Data for REED-LANE INC 359 NEW WARK,
Access order-level details, pricing data, supplier connections, and competitive analysis for REED-LANE INC 359 NEW WARK,'s Cetirizine imports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
REED-LANE INC 359 NEW WARK,
Company Profile
Multiple products · $0 total trade · Multiple categories
REED-LANE INC 359 NEW WARK, × Cetirizine
Verified from customs records
Related Analysis
Need Detailed Import Data?
Access shipment-level records, supplier contacts, and formulation details for REED-LANE INC 359 NEW WARK,.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Cetirizine. For current order-level data, contact TransData Nexus.